Drug Delivery Systems Market Research Reports & Industry Analysis

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit. Slow progress in the efficacy of the treatment of severe diseases suggests a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, and molecular biology. A drug delivery system can be administered in a variety of ways. These routes of administration can be transdermal or transmucosal, or through the gastrointestinal tract and is often termed enteral or enteric administration. Many drugs as tablets, capsules, or drops are taken orally. The choice of a delivery route is determined by patient acceptability, the properties of the drug, its access to a disease location, or effectiveness. The most important drug delivery route is the peroral route. An increasing number of drugs are protein- and peptide-based. They offer the greatest potential for more effective therapeutics, but they do not easily cross mucosal surfaces and biological membranes; and are easily degraded and at present, protein drugs are usually administered by injection.
...Show More ...Show Less


Drug Delivery Systems Industry Research & Market Reports

  • The 2026-2031 World Outlook for Closed System Transfer Devices

    ... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More

  • The 2026-2031 World Outlook for Advanced Drug Deliveries

    ... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More

  • Advanced Drug Delivery Systems – A Global Market Overview

    ... drug delivery, enhancing therapeutic outcomes while minimizing adverse effects. These systems improve drug solubility, bioavailability, and therapeutic effects while reducing side effects and dosing frequency, thus improving patient compliance and health outcomes. ADDS utilizes various ... Read More

  • Needle-Free Devices: Technologies and Global Markets

    ... performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa ... Read More

  • Global Drug Delivery Devices Market - 2025-2033

    ... period 2025-2033. The global drug delivery devices market is undergoing rapid evolution, driven by technological innovation, the rising burden of chronic diseases, and a stronger focus on patient-centered care. Advanced solutions such as smart inhalers, ... Read More

  • Polycaprolactone

    ... 8.3% over the analysis period 2024-2030. Coating & Thermoplastic polyurethane (TPU), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$141.2 Million by the end of the ... Read More

  • Intrathecal Pumps

    ... CAGR of 5.1% over the analysis period 2024-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. ... Read More

  • Connected Drug Delivery Devices

    ... 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion ... Read More

  • Intranasal Drug Delivery

    ... at a CAGR of 6.7% over the analysis period 2024-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$38.2 Billion by the end ... Read More

  • Controlled Release Drug Delivery

    ... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Feedback Regulated, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$26.3 Billion by the ... Read More

  • Nasal Drug Delivery Technology

    ... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Nasal Sprays, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$66.9 Billion by the ... Read More

  • Novel Drug Delivery Systems (NDDS)

    ... Billion by 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 21.4% CAGR and reach US$51.9 Billion by ... Read More

  • Bio-MEMS

    ... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More

  • Bio-MEMS Devices

    ... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More

  • Drug Eluting Balloons (DEBs)

    ... 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. Peripheral, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.9 Billion by the end ... Read More

  • Closed System Transfer Devices

    ... 2030, growing at a CAGR of 19.9% over the analysis period 2024-2030. Membrane-to-Membrane Systems, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$4.4 Billion by the ... Read More

  • Electronic Drug Delivery Systems

    ... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Wearable Infusion Pumps, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$8.7 Billion by ... Read More

  • Nanotechnology in Drug Delivery

    ... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 Billion by the end ... Read More

  • Global New Drug Delivery Systems Market 2025-2029

    ... the new drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More

  • Implantable Drug Delivery Devices Global Market Report 2025

    ... delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More

  • Plastics In Personalized Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (PLA, PLGA, PEG, PU, PEEK), By End Use (Pharmaceuticals & Drug Delivery, Medical Devices & Implants, Healthcare & Clinics), By Region, And Segment Forecasts, 2025 - 2030

    ... 2025 to 2030, according to a new report by Grand View Research, Inc. The plastics in personalized drug delivery systems industry is a crucial segment of the global healthcare and pharmaceutical industry, driven by the ... Read More

  • Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Small Intestine, Large Intestine, Stomach), End User (Hospitals, Diagnostic Centers), and Region - Global Forecast to 2030

    ... USD 1.30 billion by 2030 from USD 0.69 billion in 2024, at a CAGR of 11.2% during the forecast period. According to the American Cancer Society (ACS), in 2024, there were 1,52,810 new cases of ... Read More

  • Long-Acting Drug Delivery Technologies and Services Market by Compatible Dosage Form

    ... 4.62 billion by 2035, at a CAGR of 13.1% during the forecast period, till 2035. The market sizing and opportunity analysis has been segmented across the following parameters: Principle Manipulation of drug release from delivery ... Read More

  • Drug Delivery Devices Global Market Report 2025

    ... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More

  • Global Closed System Drug Transfer Devices Market 2024-2032

    ... A closed system drug transfer device (CSTD) is a specialized medical device engineered to facilitate the safe transfer of hazardous drugs while preventing contamination from external sources and blocking the escape of hazardous substances or ... Read More

< prev 1 2 3 4 5 6 7

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings
OSZAR »